| 000 | 01691 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517090058.0 | ||
| 264 | 0 | _c20170320 | |
| 008 | 201703s 0 0 eng d | ||
| 022 | _a1179-1896 | ||
| 024 | 7 |
_a10.1007/s40258-016-0238-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEl-Hamamsy, Manal H | |
| 245 | 0 | 0 |
_aEconomic Evaluation of the Combined Use of Warfarin and Low-dose Aspirin Versus Warfarin Alone in Mechanical Valve Prostheses. _h[electronic resource] |
| 260 |
_bApplied health economics and health policy _cAug 2016 |
||
| 300 |
_a431-440 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnticoagulants _xeconomics |
| 650 | 0 | 4 |
_aAspirin _xeconomics |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xeconomics |
| 650 | 0 | 4 | _aEgypt |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeart Valve Prosthesis _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOutcome and Process Assessment, Health Care |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xeconomics |
| 650 | 0 | 4 | _aQuality-Adjusted Life Years |
| 650 | 0 | 4 |
_aThromboembolism _xeconomics |
| 650 | 0 | 4 |
_aWarfarin _xeconomics |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aElsisi, Gihan H | |
| 700 | 1 | _aEldessouki, Randa | |
| 700 | 1 | _aElmazar, Mohamed M | |
| 700 | 1 | _aTaha, Ahmed S | |
| 700 | 1 | _aAwad, Basma F | |
| 700 | 1 | _aElmansy, Hossam | |
| 773 | 0 |
_tApplied health economics and health policy _gvol. 14 _gno. 4 _gp. 431-440 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s40258-016-0238-1 _zAvailable from publisher's website |
| 999 |
_c25877229 _d25877229 |
||